Review article · 2022
Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential
Pharmacology & Therapeutics, 236, 108106 · Published 3 January 2022 · DOI 10.1016/j.pharmthera.2021.108106
In brief
“Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential” is a 2022 review article by Claudia Ceci and 2 co-authors, published in Pharmacology & Therapeutics. OpenAlex counts 39 citations as of 21 November 2026, which puts it in the top 4% of works published in 2022 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 39
- Most cited in
- 2024 (10)
- Field-weighted impact
- 0.84
- References
- 421
- Authors
- 3
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ceci, C., Lacal, P. M., & Graziani, G. (2022). Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential. Pharmacology & Therapeutics, 236, 108106. https://doi.org/10.1016/j.pharmthera.2021.108106
MLA 9
Ceci, Claudia, et al. “Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.” Pharmacology & Therapeutics, vol. 236, 2022, p. 108106. https://doi.org/10.1016/j.pharmthera.2021.108106.
Chicago
Ceci, Claudia, Pedro Miguel Lacal, and Grazia Graziani. 2022. “Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.” Pharmacology & Therapeutics 236: 108106. https://doi.org/10.1016/j.pharmthera.2021.108106.
Harvard
Ceci, C., Lacal, P. M. and Graziani, G. (2022) ‘Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential’, Pharmacology & Therapeutics, 236, p. 108106. doi:10.1016/j.pharmthera.2021.108106.
IEEE
C. Ceci, P. M. Lacal, and G. Graziani, “Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential,” Pharmacology & Therapeutics, vol. 236, p. 108106, 2022, doi: 10.1016/j.pharmthera.2021.108106.
BibTeX
@article{ceci2022antibody,
title = {{Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential}},
author = {Ceci, Claudia and Lacal, Pedro Miguel and Graziani, Grazia},
journal = {Pharmacology \& Therapeutics},
year = {2022},
volume = {236},
pages = {108106},
doi = {10.1016/j.pharmthera.2021.108106},
url = {https://doi.org/10.1016/j.pharmthera.2021.108106}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2022 | 9 | |
| 2023 | 7 | |
| 2024 | 10 | |
| 2025 | 10 | |
| 2026 | 3 |
Its field-weighted citation impact is 0.84: it has been cited 0.84 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- antibody-drug conjugates
- anticancer agents
- tumor targeting
- linker stability
- drug resistance
- tumor microenvironment
- antibody engineering
- cytotoxic payloads
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Ceci, C., Lacal, P. M., & Graziani, G. (2022). Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential. Pharmacology & Therapeutics, 236, 108106. https://doi.org/10.1016/j.pharmthera.2021.108106
How many times has this paper been cited?
39 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Claudia Ceci, Pedro Miguel Lacal, Grazia Graziani.
What is the DOI of this paper?
10.1016/j.pharmthera.2021.108106, permanently at https://doi.org/10.1016/j.pharmthera.2021.108106. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.